These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16769138)

  • 1. Release pattern of cardiac biomarkers in left ventricular apical ballooning.
    Nef HM; Möllmann H; Weber M; Deetjen A; Brandt R; Hamm CW; Elsässer A
    Int J Cardiol; 2007 Jan; 115(1):128-9. PubMed ID: 16769138
    [No Abstract]   [Full Text] [Related]  

  • 2. BNP or NTproBNP? A clinician's perspective.
    Steiner J; Guglin M
    Int J Cardiol; 2008 Sep; 129(1):5-14. PubMed ID: 18378336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptide assays revisited: do we need pro-B-type natriuretic peptide?
    Emdin M; Passino C; Clerico A
    J Am Coll Cardiol; 2011 Mar; 57(12):1396-8. PubMed ID: 21414537
    [No Abstract]   [Full Text] [Related]  

  • 4. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
    Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker screening for cardiac dysfunction: the more the merrier?
    Tang WH
    Am Heart J; 2006 Jul; 152(1):1-3. PubMed ID: 16824825
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of N-terminal pro-B-type natriuretic peptide levels in critically ill children with sepsis versus acute left ventricular dysfunction.
    Fried I; Bar-Oz B; Algur N; Fried E; Gavri S; Yatsiv I; Perles Z; Rein AJ; Zonis Z; Bass R; Nir A
    Pediatrics; 2006 Oct; 118(4):e1165-8. PubMed ID: 16966393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic peptides in heart failure: their role in daily practice.
    Loboz-Grudzień K; Jaroch J
    Cardiol J; 2009; 16(1):1-3. PubMed ID: 19130409
    [No Abstract]   [Full Text] [Related]  

  • 8. No incremental clinical information of NT Pro BNP at peak exercise over resting levels in patients with impaired left ventricular function.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    Int J Cardiol; 2007 Oct; 121(2):221-3. PubMed ID: 17145088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.
    Choi SY; Lee JE; Jang EH; Kim MO; Baek H; Ki CS; Park SW; Kim DJ; Huh WS; Oh HY; Kim YG
    Nephron Clin Pract; 2008; 110(2):c93-100. PubMed ID: 18815449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of NT-proBNP as an early biological marker of cardiac dysfunction in septic shock].
    Verdier B; Chauvet JL; Tamion F; Cauliez B; Lavoinne A; Veber B; Dureuil B
    Ann Fr Anesth Reanim; 2008 Feb; 27(2):135-40. PubMed ID: 18243634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased B-type natriuretic peptide levels in patients with apical ballooning syndrome - consecutive cases report.
    Grabowski M; Filipiak KJ; Malek LA; Piatkowski R; Scislo P; Karpinski G; Opolski G
    Int J Cardiol; 2008 Mar; 124(3):404-6. PubMed ID: 17395317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the most useful and cost-effective strategy to screen for left ventricular systolic dysfunction in clinical practice?
    Yamada A; Yamada Y; Okada K
    Eur Heart J; 2006 Jun; 27(11):1382-3; author reply 1383. PubMed ID: 16613931
    [No Abstract]   [Full Text] [Related]  

  • 13. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
    Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The editor's roundtable: B-type natriuretic peptide.
    Friedewald VE; Burnett JC; Januzzi JL; Roberts WC; Yancy CW
    Am J Cardiol; 2008 Jun; 101(12):1733-40. PubMed ID: 18549849
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease.
    Austin WJ; Bhalla V; Hernandez-Arce I; Isakson SR; Beede J; Clopton P; Maisel AS; Fitzgerald RL
    Am J Clin Pathol; 2006 Oct; 126(4):506-12. PubMed ID: 16938661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
    J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
    Post F; Weilemann LS; Messow CM; Sinning C; Münzel T
    Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.